The Impact of the COVID-19 Pandemic on Alcohol Consumption Is Far From ‘One Size Fits All’

Research Society on Alcoholism

Newswise — An ongoing analysis of the effects of the COVID-19 pandemic on alcohol and related outcomes shows that COVID-related stressors experienced by study participants – including work-, financial-, and family-related stressors – are having a varied impact on individuals with and without alcohol use disorders (AUDs). These results will be shared at the 44th annual scientific meeting of the Research Society on Alcoholism (RSA), which will be held virtually this year from the 19th - 23rd of June 2021 due to the COVID-19 pandemic.

“The diverse and pervasive impact of the COVID-19 pandemic continues to unfold globally on individuals, communities, health systems, and the economy,” said Vijay Ramchandani, senior investigator and Chief of the Laboratory of Human Psychopharmacology in the Division of Intramural Clinical and Biological Research at the NIAAA. “Stress, social isolation, economic losses, and uncertainty can significantly affect mental health and alcohol use; therefore, it is critical to assess the effect of the pandemic on alcohol use and associated behaviors and outcomes.” Ramchandani will discuss these findings at the virtual RSA meeting on 20 June 2021.

Ramchandani, along with co-principal investigator Nancy Diazgranados and colleagues, invited approximately 1,200 adults who were previously enrolled in an NIAAA natural-history study – non-drinkers as well as heavy drinkers with an AUD diagnosis who had gone through inpatient treatment – to participate in the current study. Participants complete electronic surveys at intervals ranging from weekly to every six months for two years. The survey included the Alcohol Use Disorder Identification Test, along with questionnaires assessing alcohol sensitivity/tolerance, impaired control and craving, as well as perceived stress, negative life events, social isolation, resilience, depression and anxiety symptoms, and quality of life. In addition, a COVID-19 Impact Scale assessed the pandemic’s impact on employment, finances, family, and living situations as well as health symptoms and behaviors such as social-media use.

“Our study is ongoing and the full picture of the pandemic’s impact on alcohol and related outcomes will take some time to be fully understood,” said Ramchandani. “At this point in time, we have data from about 440 individuals that appear to suggest there was tremendous variability in patterns of alcohol use during the first six to eight months of the pandemic, and in the change of alcohol use from pre-pandemic levels. Overall, approximately one-fourth of the sample showed increases, one-fourth showed decreases, and about half of the sample showed no change in alcohol use during this six-to-eight-month period.”

While the patient groups showed, on average, little to no change in drinking, it was the non-patient groups that showed changes in drinking that was inversely proportional to their pre-pandemic drinking, Ramchandani added. “In other words, those that had higher drinking prior to the pandemic seemed to show a decrease in drinking, while those with lower drinking prior to the pandemic showed, disturbingly, a pattern of escalation of drinking.” That escalation appeared to be related to COVID-related stressors.

“Another important aspect to this study involves examining racial disparities of the pandemic’s impact,” said Ramchandani. “Different racial/ethnic groups have been and continue to be differentially affected by the pandemic; in fact, vulnerable groups who have experienced the highest level of stress exposure to the pandemic may be most at risk for increased alcohol use and problems following the pandemic.”



Filters close

Showing results

110 of 6054
access_time Embargo lifts in 2 days
Embargo will expire: 26-Jul-2021 11:00 AM EDT Released to reporters: 23-Jul-2021 5:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jul-2021 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: NIH Chooses University of Miami Miller School of Medicine to Head Project for Its Safe Return to In-Person School Initiative
Released: 23-Jul-2021 12:15 PM EDT
NIH Chooses University of Miami Miller School of Medicine to Head Project for Its Safe Return to In-Person School Initiative
University of Miami Health System, Miller School of Medicine

The University of Miami Miller School of Medicine is helping to lead a National Institutes of Health (NIH) COVID-19 testing initiative to safely return children to in-person school.

Released: 23-Jul-2021 11:40 AM EDT
New 'Atlas' Charts How Antibodies Attack Spike Protein Variants
Brigham and Women’s Hospital

As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions of the virus.

23-Jul-2021 8:55 AM EDT
COVID Variants and a Surge Among the Unvaccinated: Live Expert Panel for July 23rd, 2021
Newswise

Panelists will discuss the threat posed by new COVID variants and continued vaccine hesitancy.

Released: 22-Jul-2021 4:05 PM EDT
COVID-19: Patients with Malnutrition May Be More Likely to Have Severe Outcomes
Scientific Reports

Adults and children with COVID-19 who have a history of malnutrition may have an increased likelihood of death and the need for mechanical ventilation, according to a study published in Scientific Reports.

access_time Embargo lifts in 2 days
Embargo will expire: 27-Jul-2021 4:05 PM EDT Released to reporters: 22-Jul-2021 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 27-Jul-2021 4:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 26-Jul-2021 4:05 PM EDT Released to reporters: 22-Jul-2021 2:45 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jul-2021 4:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Jul-2021 2:35 PM EDT
New Insights Into Uncontrolled Inflammation in COVID-19 Patients
Queen Mary University of London

In a new study, published recently in the journal Circulation Research, scientists discover how the production of protective molecules known as specialised pro-resolving mediators (SPM) is altered in patients with COVID-19.

Released: 22-Jul-2021 2:30 PM EDT
度假旅行者需要了解的COVID-19相关信息
Mayo Clinic

许多人会利用国家法定假日出门旅行或举办聚会。由于仍有许多人需要接种COVID-19疫苗以及传染性更强的Delta变种疫苗,因此健康专家建议,如果您计划旅行或召集很多人聚会,请务必谨慎。


Showing results

110 of 6054

close
1.66292